|
|
|
|
Cat. # NKCC21-P, Rat NKCC2 Control Peptide, SIZE: 100 ug
Unlike NKCC1, NKCC2 (human 1099 aa, rat/mouse 1095 aa; calculated mol size of ~121 kDa; actual size ~150 kDa; ~45% identity with NKCC1) is most strongly expressed in the kidney (inner and outer stripes of medulla and cortical thick ascending limb), and macula densa. NKCC2 plays a critical role in transcellular absorption of Na+-Cl- by the medullary and cortical TALH, and a secondary role in the paracellular transport of Na-Ca and Mg. Mutations in the NKCC2 gene result in Bartter's syndrome, an inherited disease characterized by hypokalemic metabolic alkalosis, hypercalciuria, salt wasting, and volume depletion. Source of Antigen and Antibodies Antigen: 15aa peptide of Rat NKCC2; Designated (NKCC21-P). Recommended Usage Western Blotting (1:1K-5K for neat serum and 1-10 ug/ml for affinity pure using Chemiluminescence technique). ELISA (1:10K-1:100K; using 50-100 ng of control peptide/well). Histochemistry & Immunofluorescence: Not tested. We recommend the use of affinity purified antibody at 2-20 ug/ml. Specificity & Cross-reactivity The 15 AA rat NKCC21-P control peptide 100% conserved in mouse, 87% in human and rabbit NKCC2. No significant sequence homology is detected with NKCC1 or TSC. Antibody cross-reactivity in various species has not been studied. The NKCC21-P control peptide, because of its small size (<2 kDa), is not suitable for Western. It should be used in ELISA, dot blot or to neutralize antibody and confirm specificity of antibody. References: (1). Gamba G et al (1994) J Biol. Chem. 269, 17713; Simon DB et al (1996) Nature Genet. 13, 183; Mount DB et al (1995) J Am. Soc. Nephrol. 6, 347; Igarashi P et al (1995) Am. J. Physiol. 269, F405; Haas M et al (1987) Am. J. Physiol. 253, C243; Mount DB et al (1998) J. Exptl. Biol. 201, 2091 (review). |
|
|